Daiichi Sankyo's net income FY 2013-2022

Published by
Catharina Klein,
Nov 1, 2024
In the fiscal year 2022, Daiichi Sankyo's profit amounted to approximately 109 billion Japanese yen. Figures peaked in fiscal 2014, reaching around 322.1 billion Japanese yen. The main products of the Japanese pharmaceutical company include oncology medications, cardiovascular medications, and vaccines.

Annual profit of Daiichi Sankyo Co., Ltd. from fiscal years 2013 to 2022 (in billion Japanese yen)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

October 2023

Region

Japan

Survey time period

fiscal year 2013 to 2022; the company's fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Special properties

profit attributable to owners of the company

Supplementary notes

Figures are based on International Financial Reporting Standards (IFRS).
100 Japanese yen equal 0.67 U.S. dollars or 0.62 euros as of December 2023.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Vaccine industry in China "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Vaccine industry in China

Background

6

Market overview

6

Class I vaccines

6

Class II vaccines

6

International trade

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in JapanVaccine industry in ChinaPharmaceuticals in India
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.